This program was revealed to be under the control of Trem2 and necessary to counteract obesity-related metabolic disorders, as Trem2 deficiency enhanced HFD-induced weight gain, hypercholesterolemia, glucose intolerance and IR [5]. This evidence concerns the gene TREM2 and obesity due to melanocortin 4 receptor deficiency.